Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TXMDthis companyTherapeuticsMD, Inc.	$1.69	-33.13×	0.7×	6.24×	-5.78×	-817.2%	100.0%	-139.4%	-18.8%	-2.1%	-12.5%	12.9%	0.23×	0.46×	-526.75×	3.02×	0.0%	4	-34.36	2	C+
AMSAmerican Shared Hospital Services	$1.24	-9.17×	0.58×	0.5×	8.14×	182.4%	18.0%	-7.2%	-5.5%	-6.5%	-3.4%	-32.5%	0.94×	4.71×	-1.28×	0.76×	0.0%	4	0.59	2	C
AYTUAytu BioPharma, Inc.	$1.86	-1.85×	0.75×	0.46×	-4.17×	-322.8%	64.0%	-14.4%	-24.8%	-40.4%	-14.2%	12.3%	0.51×	1.87×	4.39×	1.13×	0.0%	4	-4.22	2	C
BFRIBiofrontera Inc.	$0.84	-0.55×	0.55×	0.14×	-0.61×	-3679.1%	78.7%	-21.9%	-25.3%	-100.5%	-53.8%	-230.5%	0.59×	0.03×	-20.24×	1.52×	0.0%	2	-6.17	1	C-
ERNAErnexa Therapeutics Inc.	$1.93	-0.54×	3.15×	0×	-0.45×	-4.7%	0.0%	0.0%	0.0%	-586.6%	-316.6%	-93.2%	0.2×	0.1×	-345.15×	1.01×	0.0%	2	-64.61	2	B-
MPLTMapLight Therapeutics, Inc.	$7.37	-4.8×	1.69×	0×	-4.56×	-86.3%	0.0%	0.0%	0.0%	-35.2%	-36.4%	-17.9%	0.01×	0.25×	0×	20.01×	0.0%	2	5.7	2	C
Peer median	—	-1.85×	0.75×	0.14×	-0.61×	-86.3%	18.0%	-7.2%	-5.5%	-40.4%	-36.4%	-32.5%	0.51×	0.25×	-1.28×	1.13×	0.0%	2	-4.22	2	—